Management of diabetes mellitus in Cushing's syndrome

Neuroendocrinology

Volumn 92, Issue SUPPL. 1, 2010, Pages 82-85

  Munir, Alia ^a   Newell Price, John ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cortisol; Diabetes; Insulin resistance; Ketoconazole; Metformin; Metyrapone

Indexed keywords

GLUCOCORTICOID; HEMOGLOBIN A1C; KETOCONAZOLE; METFORMIN; METYRAPONE; MITOTANE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SULFONYLUREA DERIVATIVE;

CONFERENCE PAPER; CUSHING SYNDROME; DIABETES MELLITUS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; STEROIDOGENESIS;

CUSHING SYNDROME; DIABETES MELLITUS; ENZYME INHIBITORS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; KETOCONAZOLE; METFORMIN; METYRAPONE;

EID: 77956524615     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314316     Document Type: Conference Paper

References (10)

1. Van Der Goes MC, Jacobs JW, Boers M, et al: Patients' and rheumatologists' perspectives on glucocorticoids an exercise to improve the implementation of the EULAR recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2010;69:1015-1021.
2. Gulliford MC, Charlton J, Latinovic R: Risk of diabetes as sociated with prescribed gluco-corticoids in a large population. Diabetes Care 2006; 29:2728-2729.
3. Clore JN, Thurby-Hay L: Glucocorticoid-in-duced hyperglycemia. Endocr Pract 2009; 15: 469-474.
4. Friedman TC, Mastorakos G, Newman TD, Mullen NM, Horton EG, Costello R, Papado-poulos NM, Chrousos GP: Carbohydrate and lipid metabolism in endogenous hyper-cortisolism: shared features with metabolic syndrome X and NIDDM. Endocr J 1996; 43: 645-655.
5. Biering H, Knappe G, Gerl H, Lochs H: Prevalence of diabetes in acromegaly and Cush-ing syndrome. Acta Med Austriaca 2000; 27: 27-31.
6. Pecori Giraldi F, Moro M, Cavagnini F, Study Group on the Hypothalamo-Pitu-itary-Adrenal Axis of the Italian Society of Endocrinology: Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab 2003; 88: 155 4-1558.
7. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G: High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) 2004; 61:768-777.
8. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G: Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999; 84:2664-2672.
9. Suliman AM, Freaney R, Smith TP, McBrinn Y, Murray B, McKenna TJ: The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency. Clin En-docrinol (Oxf) 2003; 59: 380-387.
10. Ebrecht M, Buske-Kirschbaum A, Hellham-mer D, Kern S, Rohleder N, Walker B, Kirschbaum C: Tissue specificity of gluco-corticoid sensitivity in healthy adults. J Clin Endocrinol Metab 2000; 85: 3733-3739.